prednisolone - CISMeF

Preferred Label : prednisolone;

MeSH definition : A glucocorticoid with the general properties of the corticosteroids. It is the drug of choice for all conditions in which routine systemic corticosteroid therapy is indicated, except adrenal deficiency states.;

MeSH hyponym : predate; predonine; Di-Adreson-F; Di Adreson F; DiAdresonF;

MeSH CAS label : Pregna-1,4-diene-3,20-dione, 11,17,21-trihydroxy-, (11beta)-;

MeSH Related Number : 50-24-8 (Prednisolone);

Registry Number MeSH : 50-24-8;

Wikipedia link : https://en.wikipedia.org/wiki/Prednisolone;

Codes EINECS : 200-021-7;

Is substance : O;

UNII : 9PHQ9Y1OLM;

InChIKey : OIGNJSKKLXVSLS-VWUMJDOOSA-N;

Details

Origin ID

D011239;

UMLS CUI

C0032950;

ATC code(s)
- prednisolone [ATC Code]
- prednisolone [ATC Code]
- prednisolone [ATC Code]
- prednisolone [ATC Code]
- prednisolone and antiinfectives [ATC Code]
- prednisolone and promethazine [ATC Code]
- prednisolone, combinations [ATC Code]
ATC code(s)
- abiraterone and prednisolone [ATC Code]
- prednisolone [ATC Code]
- prednisolone [ATC Code]
- prednisolone [ATC Code]
- prednisolone [ATC Code]
- prednisolone [ATC Code]
- prednisolone [ATC Code]
- prednisolone [ATC Code]
- prednisolone [ATC Code]
- prednisolone [ATC Code]
- prednisolone [ATC Code]
- prednisolone [ATC Code]
- prednisolone and antibiotics [ATC Code]
- prednisolone and antiinfectives [ATC Code]
- prednisolone and antiinfectives [ATC Code]
- prednisolone and antiinfectives [ATC Code]
- prednisolone and antiseptics [ATC Code]
- prednisolone and mydriatics [ATC Code]
- prednisolone and promethazine [ATC Code]
- prednisolone, combinations [ATC Code]
- prednisolone, combinations [ATC Code]
Allowable qualifiers
- administration and dosage [MeSH Qualifier]
- adverse effects [MeSH Qualifier]
- agonists [MeSH Qualifier]
- analogs and derivatives [MeSH Qualifier]
- analysis [MeSH Qualifier]
- antagonists and inhibitors [MeSH Qualifier]
- blood [MeSH Qualifier]
- cerebrospinal fluid [MeSH Qualifier]
- chemical synthesis [MeSH Qualifier]
- chemistry [MeSH Qualifier]
- classification [MeSH Qualifier]
- contraindications [MeSH Qualifier]
- economics [MeSH Qualifier]
- history [MeSH Qualifier]
- immunology [MeSH Qualifier]
- isolation and purification [MeSH Qualifier]
- metabolism [MeSH Qualifier]
- pharmacokinetics [MeSH Qualifier]
- pharmacology [MeSH Qualifier]
- poisoning [MeSH Qualifier]
- radiation effects [MeSH Qualifier]
- standards [MeSH Qualifier]
- supply and distribution [MeSH Qualifier]
- therapeutic use [MeSH Qualifier]
- toxicity [MeSH Qualifier]
- urine [MeSH Qualifier]
CISMeF manual mappings
- Prednisolone adverse reaction (disorder) [SNOMED CT concept]
- Prednisolone measurement (procedure) [SNOMED CT concept]
- prednisolone [Substance BNPC]
Currated CISMeF NLP mapping
- Prednisolone [ICD-11 Extension code]
- Prednisolone [NCIt concept]
- Prednisolone (substance) [SNOMED CT concept]
- prednisoLONE [LOINC component]
False automatic mappings
- Predation (finding) [SNOMED CT concept]
Indexing information
- prednisolone receptor [MeSH Supplementary Concept]
Manual BTNT mappings - CISMeF
- Prednisolone hexanoate (substance) [SNOMED CT concept]
Pharmacological action(s)
- anti-inflammatory agents [MeSH Descriptor]
- antineoplastic agents, hormonal [MeSH Descriptor]
- glucocorticoids [MeSH Descriptor]
Record concept(s)
- Di-Adreson-F [MeSH concept]
- predate [MeSH concept]
- prednisolone [MeSH concept]
- predonine [MeSH concept]
Related MeSH Supplementary Concept(s)
- 06-Paris-LA-66 protocol [MeSH Supplementary Concept]
- 1(beta)-D-arabinofuranosylcytosine-5'-diphosphate prednisolone [MeSH Supplementary Concept]
- 16-benzyloxycarbonyl-17-deoxyprednisolone [MeSH Supplementary Concept]
- 16-hydroxyprednisolone [MeSH Supplementary Concept]
- 16-isopropoxycarbonyl-17-deoxyprednisolone [MeSH Supplementary Concept]
- 17,21-dihydroxypregna-1,4-diene-3,20-dione 17-acetate [MeSH Supplementary Concept]
- 17a-hydroxy-17a-hydroxymethyl-17-keto-homo-D-prednisolone phosphate [MeSH Supplementary Concept]
- 18-hydroxyprednisolone [MeSH Supplementary Concept]
- 20-dihydroprednisolonic acid [MeSH Supplementary Concept]
- 6-hydroxybudesonide [MeSH Supplementary Concept]
- 6-hydroxyprednisolone [MeSH Supplementary Concept]
- AAAP protocol [MeSH Supplementary Concept]
- ABEP protocol 1 [MeSH Supplementary Concept]
- ABP protocol 2 [MeSH Supplementary Concept]
- ACMP protocol [MeSH Supplementary Concept]
- ACOB regimen [MeSH Supplementary Concept]
- ACOP-E protocol [MeSH Supplementary Concept]
- AL851 protocol [MeSH Supplementary Concept]
- ALHR88 protocol [MeSH Supplementary Concept]
- ALL-BFM-95 protocol [MeSH Supplementary Concept]
- ARA-COP protocol [MeSH Supplementary Concept]
- AVIP protocol [MeSH Supplementary Concept]
- AVPP protocol [MeSH Supplementary Concept]
- AclBEP protocol [MeSH Supplementary Concept]
- B-DOMP protocol [MeSH Supplementary Concept]
- BCPP protocol [MeSH Supplementary Concept]
- BEMOP-CA protocol [MeSH Supplementary Concept]
- BH-AC-AMP protocol [MeSH Supplementary Concept]
- BH-AC-DMP protocol [MeSH Supplementary Concept]
- BHAC-AMP protocol [MeSH Supplementary Concept]
- BHAC-DMPV protocol [MeSH Supplementary Concept]
- BOAP protocol [MeSH Supplementary Concept]
- BOVAPEC protocol [MeSH Supplementary Concept]
- CAOP protocol [MeSH Supplementary Concept]
- CAPE-PALE protocol [MeSH Supplementary Concept]
- CAPT protocol [MeSH Supplementary Concept]
- CEOP protocol 2 [MeSH Supplementary Concept]
- CEOP-IMVP-Dexa regimen [MeSH Supplementary Concept]
- CEVBP protocol [MeSH Supplementary Concept]
- CFMPV protocol [MeSH Supplementary Concept]
- CHOEP protocol [MeSH Supplementary Concept]
- CHOP-V-MMV protocol [MeSH Supplementary Concept]
- CHOP-VP16 protocol [MeSH Supplementary Concept]
- CIOP protocol [MeSH Supplementary Concept]
- CMOPP protocol [MeSH Supplementary Concept]
- CMPP protocol [MeSH Supplementary Concept]
- COP-B protocol [MeSH Supplementary Concept]
- COP-PAF protocol [MeSH Supplementary Concept]
- CROP protocol [MeSH Supplementary Concept]
- CTVP protocol [MeSH Supplementary Concept]
- CVAP-B protocol [MeSH Supplementary Concept]
- CVPP regimen [MeSH Supplementary Concept]
- ChlVPP protocol [MeSH Supplementary Concept]
- ChlVPP-EVA regimen [MeSH Supplementary Concept]
- Corti-Dynexan [MeSH Supplementary Concept]
- D-ZAPO protocol [MeSH Supplementary Concept]
- DC(M)VP protocol [MeSH Supplementary Concept]
- DCMP protocol [MeSH Supplementary Concept]
- DCTP regimen [MeSH Supplementary Concept]
- DCVP-1-asp protocol [MeSH Supplementary Concept]
- DOAPP protocol [MeSH Supplementary Concept]
- DOPP-protocol [MeSH Supplementary Concept]
- DVP (daunomycin) [MeSH Supplementary Concept]
- DVP regimen [MeSH Supplementary Concept]
- DVP-M-CHOP protocol [MeSH Supplementary Concept]
- EMLP protocol [MeSH Supplementary Concept]
- EPVP protocol [MeSH Supplementary Concept]
- EVP protocol [MeSH Supplementary Concept]
- Ep4 solution [MeSH Supplementary Concept]
- FEMP protocol [MeSH Supplementary Concept]
- FIB-P protocol [MeSH Supplementary Concept]
- GIMEMA LAL 0288 protocol [MeSH Supplementary Concept]
- HOPE-Bleo protocol [MeSH Supplementary Concept]
- HR-1 protocol [MeSH Supplementary Concept]
- HR-2 protocol [MeSH Supplementary Concept]
- HR-3 protocol [MeSH Supplementary Concept]
- IVAP protocol [MeSH Supplementary Concept]
- IVEP protocol [MeSH Supplementary Concept]
- LEAMP protocol [MeSH Supplementary Concept]
- LNH 84 protocol [MeSH Supplementary Concept]
- LOP protocol [MeSH Supplementary Concept]
- LOPP protocol 1 [MeSH Supplementary Concept]
- LSG15 regimen [MeSH Supplementary Concept]
- M-BACOP protocol [MeSH Supplementary Concept]
- MACOP-B regimen [MeSH Supplementary Concept]
- MAPECO protocol [MeSH Supplementary Concept]
- MATCOP regimen [MeSH Supplementary Concept]
- MCNU-VMP protocol [MeSH Supplementary Concept]
- MCOP protocol [MeSH Supplementary Concept]
- MCP protocol [MeSH Supplementary Concept]
- MCPD protocol [MeSH Supplementary Concept]
- MCPP protocol [MeSH Supplementary Concept]
- MECHOP-BM protocol [MeSH Supplementary Concept]
- MECP protocol [MeSH Supplementary Concept]
- MEPP protocol [MeSH Supplementary Concept]
- ML-Y1 protocol [MeSH Supplementary Concept]
- MMIP protocol [MeSH Supplementary Concept]
- MMPP protocol [MeSH Supplementary Concept]
- MOPA-6 protocol [MeSH Supplementary Concept]
- MP combination [MeSH Supplementary Concept]
- MSK-NY-II protocol, modified [MeSH Supplementary Concept]
- MVPP protocol [MeSH Supplementary Concept]
- N-(prednisolone-21-succinylaminohexyl)-N'-fluoresceinyl-thiourea [MeSH Supplementary Concept]
- N-propyl-20-dihydroprednisolonamide [MeSH Supplementary Concept]
- NEO-MACOP-B protocol [MeSH Supplementary Concept]
- NOP protocol [MeSH Supplementary Concept]
- NOPE protocol [MeSH Supplementary Concept]
- OPAL protocol [MeSH Supplementary Concept]
- OPEC protocol 2 [MeSH Supplementary Concept]
- P-COMM-B protocol [MeSH Supplementary Concept]
- PABlOE protocol [MeSH Supplementary Concept]
- PACE-BOM protocol [MeSH Supplementary Concept]
- PACEBO protocol [MeSH Supplementary Concept]
- PACET protocol [MeSH Supplementary Concept]
- PATCO protocol [MeSH Supplementary Concept]
- PETHEMA ALL-96 protocol [MeSH Supplementary Concept]
- PMitCEBO protocol [MeSH Supplementary Concept]
- POCAL protocol [MeSH Supplementary Concept]
- POEM-Bleo protocol [MeSH Supplementary Concept]
- RACOP protocol [MeSH Supplementary Concept]
- Stanford-NCOG protocol [MeSH Supplementary Concept]
- TCCSG B-8801 protocol [MeSH Supplementary Concept]
- TOAP protocol [MeSH Supplementary Concept]
- TRAMPCO protocol [MeSH Supplementary Concept]
- TRAMPCOL protocol [MeSH Supplementary Concept]
- TSC-5 [MeSH Supplementary Concept]
- TSOP protocol [MeSH Supplementary Concept]
- UKALL X protocol [MeSH Supplementary Concept]
- VAD1 regimen [MeSH Supplementary Concept]
- VAMP combination [MeSH Supplementary Concept]
- VAMP-EEE protocol [MeSH Supplementary Concept]
- VAP protocol [MeSH Supplementary Concept]
- VAP-cyclo protocol [MeSH Supplementary Concept]
- VAPA protocol [MeSH Supplementary Concept]
- VCP protocol 2 [MeSH Supplementary Concept]
- VCRP protocol [MeSH Supplementary Concept]
- VCSP protocol [MeSH Supplementary Concept]
- VEEP regimen [MeSH Supplementary Concept]
- VEMFAH protocol [MeSH Supplementary Concept]
- VEMP protocol 1 [MeSH Supplementary Concept]
- VEMP protocol 3 [MeSH Supplementary Concept]
- VEP protocol [MeSH Supplementary Concept]
- VEP-THP protocol [MeSH Supplementary Concept]
- VEPA-B protocol [MeSH Supplementary Concept]
- VEPA-L protocol [MeSH Supplementary Concept]
- VEPA-M protocol [MeSH Supplementary Concept]
- VHCP protocol [MeSH Supplementary Concept]
- VIM3-ARA C regimen [MeSH Supplementary Concept]
- VINAP protocol [MeSH Supplementary Concept]
- VIPP-BM protocol [MeSH Supplementary Concept]
- VP protocol [MeSH Supplementary Concept]
- VQEP protocol [MeSH Supplementary Concept]
- acepreval [MeSH Supplementary Concept]
- aluminum phosphate, prednisolone drug combination [MeSH Supplementary Concept]
- anacal [MeSH Supplementary Concept]
- chait's C solution [MeSH Supplementary Concept]
- chloromethyl 9-fluoro-17-ethoxycarbonyloxy-11-hydroxy-16-methylandrosta-1,4-dien-3-one-17-carboxylate [MeSH Supplementary Concept]
- dexpanthenol, lidocaine, prednisolone, triclosan drug combination [MeSH Supplementary Concept]
- dichlorisone acetate [MeSH Supplementary Concept]
- dipyridamole, prednisolone drug combination [MeSH Supplementary Concept]
- dutimelan [MeSH Supplementary Concept]
- fluoromethyl 17-ethoxycarbonyloxy-11-hydroxyandrosta-1,4-dien-3-one-17-carboxylate [MeSH Supplementary Concept]
- fokalmin [MeSH Supplementary Concept]
- masticort PS [MeSH Supplementary Concept]
- mazipredone [MeSH Supplementary Concept]
- mecortolon [MeSH Supplementary Concept]
- methyl 11,17,21-trihydroxy-3,20-dioxopregna-1,4-diene-16-carboxylate [MeSH Supplementary Concept]
- methyl 11-hydroxy-3,20-dioxo-1,4-pregnadien-21-oate [MeSH Supplementary Concept]
- methyl 17,20-acetonidodihydroprednisolonate [MeSH Supplementary Concept]
- methyl 20-dihydroprednisolonate [MeSH Supplementary Concept]
- methyl prednisolonate [MeSH Supplementary Concept]
- mycosolon [MeSH Supplementary Concept]
- neomycin, prednisolone, surfen, trypsin-chymotrypsin drug combination [MeSH Supplementary Concept]
- neopredin [MeSH Supplementary Concept]
- non-Hodgkin's lymphoma protocol 8503 [MeSH Supplementary Concept]
- nystacorton [MeSH Supplementary Concept]
- palmitoyl prednisolone [MeSH Supplementary Concept]
- prednefrin [MeSH Supplementary Concept]
- predni aquos opthiole [MeSH Supplementary Concept]
- prednicarbate [MeSH Supplementary Concept]
- prednisolone 17-ethylcarbonate [MeSH Supplementary Concept]
- prednisolone 21-((4'-nitrooxymethyl)benzoate) [MeSH Supplementary Concept]
- prednisolone 21-3-sulfobenzoate [MeSH Supplementary Concept]
- prednisolone 21-ethylcarbonate [MeSH Supplementary Concept]
- prednisolone 21-glucoside [MeSH Supplementary Concept]
- prednisolone 21-stearoylglycolate [MeSH Supplementary Concept]
- prednisolone acetate [MeSH Supplementary Concept]
- prednisolone farnesylate [MeSH Supplementary Concept]
- prednisolone hemisuccinate [MeSH Supplementary Concept]
- prednisolone phosphate [MeSH Supplementary Concept]
- prednisolone succinate-carnitine [MeSH Supplementary Concept]
- prednisolone tebutate [MeSH Supplementary Concept]
- prednisolone tetrahydrophthalate [MeSH Supplementary Concept]
- prednisolone-3,20-bisguanylhydrazone [MeSH Supplementary Concept]
- prednylidene [MeSH Supplementary Concept]
- presocyl [MeSH Supplementary Concept]
- repredsol [MeSH Supplementary Concept]
- rifocort [MeSH Supplementary Concept]
- socketol [MeSH Supplementary Concept]
- st jude's regimen [MeSH Supplementary Concept]
- stanford university protocol [MeSH Supplementary Concept]
- star poly(ethylene glycol)hydrazide-prednisolone-20-hydrazone [MeSH Supplementary Concept]
- steroidal 17-yl-alpha-oxothiocarboxamides [MeSH Supplementary Concept]
- sulfanizolone [MeSH Supplementary Concept]
Semantic type(s)
- Organic Chemical [UMLS semantic type]
- Pharmacologic Substance [UMLS semantic type]
UMLS correspondences (same concept)
- Prednisolone [ICD-11 Extension code]
- Prednisolone [NCIt concept]
- Prednisolone (substance) [SNOMED CT concept]
- Product containing prednisolone (medicinal product) [SNOMED CT concept]
- prednisoLONE [LOINC component]
- prednisolone [ATC Code]
- prednisolone [ATC Code]
- prednisolone [ATC Code]
- prednisolone [ATC Code]
- prednisolone [ATC Code]
- prednisolone [ATC Code]
- prednisolone [ATC Code]
- prednisolone [ATC Code]
- prednisolone [ATC Code]
- prednisolone [ATC Code]
- prednisolone [Substance BNPC]
- prednisolone [ATC Code]
- prednisolone preparation [SNOMED Notion]
Validated automatic mappings to BTNT
- prednisolone [ATC Code]
- prednisolone [ATC Code]
- prednisolone [ATC Code]
- prednisolone [ATC Code]
- prednisolone [ATC Code]
- prednisolone [ATC Code]
- prednisolone [ATC Code]
- prednisolone [ATC Code]
- prednisolone [ATC Code]
- prednisolone [ATC Code]
- prednisolone [ATC Code]

Keyword's position in hierarchy(ies) :

Main resources

You can consult :

recommendations
documents concerning education
documents for patients